世界のデキサメタゾン市場 – 業界動向と2028年までの予測

デキサメタゾンの市場分析と洞察：世界のデキサメタゾン市場

デキサメタゾン市場は、2021年から2028年の予測期間に市場成長を遂げると予想されています。データブリッジマーケットリサーチは、市場規模が2028年までに46億3,401万米ドルに達し、上記の予測期間中に6.65%のCAGRで成長すると分析しています。

デキサメタゾンは、強力な抗炎症性合成副腎皮質ステロイドで、体内に炎症の根源となる物質が侵入するのを防ぐのに役立ちます。また、アレルギー疾患や皮膚疾患の炎症、副腎の問題、関節炎、重度のアレルギー、喘息、血液や骨髄の問題、皮膚疾患、多発性硬化症の再発、腎臓の問題など、さまざまな炎症性疾患の治療にも使用されます。

突然の爆発的な感染拡大により、重篤なCOVID-19患者の救命治療薬としてのデキサメタゾンの使用が急増していることは、デキサメタゾン市場の成長と需要を強める重要な要因の1つです。さらに、研究開発への堅調な投資も、2021年から2028年の予測期間にわたる世界市場の上昇に貢献しています。また、ウイルス性疾患の発生率の高さ、デキサメタゾンの使用に関する意識の高まり、パンデミックの影響の大きさも、市場の成長を促進しています。同様に、死亡率の急速な増加とCOVID-19に対するデキサメタゾンの緊急使用の承認も、上記の予測期間における市場の成長を押し上げています。さまざまな炎症性疾患の急速な増加と疾患の有病率の増加は、デキサメタゾン市場の拡大をさらに加速させ、2021年から2028年の予測期間において市場に大きな成長の機会を提供しています。

しかし、デキサメタゾンの使用に伴うさまざまな副作用は、上記の予測期間中のデキサメタゾン市場の成長を妨げると予想され、一方で開発中のワクチンなどの予防措置の増加は、デキサメタゾン市場の成長に悪影響を及ぼす可能性があります。

This dexamethasone market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on dexamethasone market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Dexamethasone Market Scope and Market Size

Dexamethasone market is segmented on the basis of formulation type, patient type, application and end users. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• The formulation type segment of dexamethasone market is segmented into liquid, tablet, solution for injection and other.
• On the basis of patient type, the dexamethasone market is segmented into adult, pediatric and geriatric.
• On the basis application, the dexamethasone market is segmented into anti-inflammatory and immunosuppressant effects, respiratory distress syndrome, COVID-19 and others.
• The end users segment of the dexamethasone market is segmented into hospitals, clinics, pharmacy & drug stores and online pharmacies.

Dexamethasone Market Country Level Analysis

Dexamethasone market is analyzed and market size insights and trends are provided by country, formulation type, patient type, application and end users as referenced above.

The countries covered in the  dexamethasone market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the dexamethasone market owing to the rapidly rising cases of covid-19 and high prevalence of diseases within the region. Asia-Pacific is expected to expand at significant growth rate over the forecast period of 2021 to 2028 because of the rising prevalence of viral disease outbreak and the strong presence of major manufacturers of Dexamethasone in this region.

The country section of the dexamethasone market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Dexamethasone market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for dexamethasone market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the dexamethasone market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Dexamethasone Market Share Analysis

Dexamethasone market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to dexamethasone market.

デキサメタゾン市場レポートで取り上げられている主要企業は、Cadila Pharmaceuticals、Wockhardt、Dwarkesh Pharmaceuticals Private Limited、Schwitz Biotech、Lexine Technochem Pvt. Ltd.、THERAWIN FORMULATIONS、SHERVOTEC PHARMACEUTICAL、Acichem Laboratories、Quality Nex Gen.、Kern Pharma、Symbiotec Pharma Lab Pvt. Ltd.、AuroMedics Pharma LLC、Fresenius Kabi AG、Getwell Oncology Pvt Ltd、LGM Pharma、Hikma Pharmaceuticals PLC、Mylan NV、McKesson Medical-Surgical Inc.、AdvaCare Pharma、Cisen Pharmaceuticals India Private Limited.など、国内外の企業です。市場シェアデータは、世界、北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、南米で個別に入手できます。DBMR アナリストは、競争力を理解し、各競合他社の競合分析を個別に提供します。

SKU-58872